Related Experiment Video
Updated: Jul 28, 2026
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
Monoclonal antibodies in the treatment of lung cancer
1Department of Thoracic Surgery, Bajcsy-Zsilinszky Hospital, 89-91 Maglódi Street, Budapest 1106, Hungary. rgriga@freemail.hu
Background:
Lung cancer is an aggressive disease and its conventional therapy is far from success. There is a strong need for new, better approaches to improve survival, symptom control and quality of life.
Methods:
The authors searched the literature for indexed articles published over the past 30 years from Pubmed concentrating on all possibilities of monoclonal antibodies in the therapy of tumours and especially of lung cancer.
Results:
The search resulted in more then 200 published articles. Important major reports of the pre-clinical/clinical investigations of monoclonal antibodies in the therapy of tumours, with an emphasis on lung cancer were reviewed, screened and tracked for other relevant publications and the yielded data were summarized and systematized.
Conclusion:
It is concluded, that immunotherapy and the reviewed use of monoclonal antibodies in the therapy of tumours (including lung cancer) certainly carries a hope. However, studies of this topic are in a wide range of phases, from experiments to clinical trials, thereby their results are not comparable with each other. Based on the data available though the authors feel that active immunization with monoclonal antibodies as anti-idiotype vaccines, and antibody targeting with immunoconjugates (immunotoxins, radioimmunoconjugates and chemoimmunoconjugates) are the most promising methods. Radioimmunoguided surgery and immunoguided focal ablation are also valuable. Anti-growth factor monoclonal antibodies are the most evaluated agents so far. They certainly have an objective effect, though they are still not the 'magic bullets', waited for by many clinicians. The use of monoclonal antibodies against the escape mechanisms of tumours can be a good auxiliary method. There are too little data on the value of antibodies directly targeting tumour cells and on combined passive immunotherapy. Due to constant research, other modalities, such as prodrug activation, T cell activation, the use of intrabodies, T bodies, and conjugated antibody fragments might also prove to be valuable.
Insights
Monoclonal antibodies offer hope for lung cancer therapy, with immunoconjugates and anti-idiotype vaccines showing promise. Further research is needed to compare diverse treatment phases and optimize outcomes.
Area of Science:
- Oncology
- Immunotherapy
- Biotechnology
Background:
- Lung cancer remains an aggressive disease with limited conventional therapy success.
- There is a critical need for novel therapeutic strategies to improve patient survival and quality of life.
Purpose of the Study:
- To review the literature on monoclonal antibodies for tumor therapy, with a specific focus on lung cancer.
- To identify promising monoclonal antibody-based approaches for lung cancer treatment.
Main Methods:
- A comprehensive literature search of PubMed was conducted for articles published over the past 30 years.
- Indexed articles focused on monoclonal antibodies in tumor and lung cancer therapy were reviewed, screened, and data were systematized.
Main Results:
- Over 200 articles were identified, with a focus on pre-clinical and clinical investigations of monoclonal antibodies in lung cancer.
- Anti-growth factor antibodies show objective effects but are not yet definitive cures. Immunoconjugates and anti-idiotype vaccines are identified as highly promising.
Conclusions:
- Monoclonal antibody-based immunotherapy holds significant potential for lung cancer treatment.
- Active immunization (anti-idiotype vaccines) and antibody targeting (immunoconjugates) are the most promising modalities.
- Further research is essential to compare diverse treatment phases and explore novel antibody-based strategies like prodrug activation and T cell activation.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy